Atrium Health Levine Cancer

04/17/2026

Go Ava! 💙

04/16/2026

03/26/2026

03/05/2026

New research highlights a promising new approach to treating brain metastases, one of the most difficult complications of lung cancer.

The study by Wake Forest University School of Medicine was published in Nature Biomedical Engineering. In it, researchers engineered macrophages, immune cells that naturally cross the bloodbrain barrier, to recognize and attack cancer cells in the brain. These CAR macrophages successfully entered brain tumor sites, reduced tumor growth, and extended survival in early models, with fewer signs of toxicity than CART approaches.

The findings point to a potential new path for immunotherapy in the brain, where treatment options remain limited.

Learn more. https://bit.ly/4d0fkIX

02/26/2026

02/25/2026

02/19/2026

02/13/2026

Atrium Health Levine Cancer’s Survivorship Clinic is a critical part of the Department of Supportive Care and offers a place for cancer survivors to heal and thrive in recovery.

02/12/2026

A global study led by Wake Forest University School of Medicine and Atrium Health Levine Cancer shows a major advance for patients with highrisk essential thrombocythaemia (ET) — a rare blood cancer with limited treatment options.

The SURPASSET clinical trial found that ropeginterferon alfa2b delivers significantly better disease control, fewer symptoms and fewer serious complications compared to the current secondline therapy for patients who can’t tolerate hydroxyurea.

With the FDA now reviewing an application to expand the use of ropeginterferon alfa2b for ET, this study marks a meaningful step forward for patients and clinicians.

Learn more.
https://newsroom.wakehealth.edu/news-releases/2026/02/global-study-marks-major-treatment-advance-for-blood-cancer

02/10/2026

Cancer treatments can save lives, but they can also impact the heart. Learn why heart health is essential for cancer patients and survivors and how cardio-oncologists help protect you.